Call for papers - HIV long-acting treatments: prophylactic and therapeutic - BioMed Central

BMC Infectious Diseases is calling for submissions to our Collection on HIV long-acting treatments: prophylactic and therapeutic. 

The field of HIV research has made remarkable strides since the identification of the virus in the early 1980s. Over the decades, advances in antiretroviral therapy (ART) have significantly improved the quality of life for people living with HIV and have played a pivotal role in reducing transmission rates. Yet, the quest for more effective, convenient, and accessible treatments continues.

In recent years, long-acting treatments have emerged as a promising frontier in HIV management, encompassing both prophylactic and therapeutic modalities. These innovative approaches hold the potential to revolutionize the landscape of HIV care, addressing not only the challenges of treatment adherence but also expanding the toolkit for prevention strategies.

This Collection calls for novel research, spanning from laboratory-based investigations to clinical trials and public health studies, in order to shed light on the diverse aspects of long-acting treatments for HIV.

Topics of interest include but are not limited to:

• Long-acting antiretroviral therapies: research exploring the development, mechanisms, and clinical applications of long-acting antiretroviral agents, including their efficacy, safety, and impact on treatment outcomes
• Pre-exposure prophylaxis (PrEP): investigations into long-acting PrEP modalities and their potential to enhance HIV prevention efforts, particularly among high-risk populations
• Treatment and prevention integration: studies assessing the feasibility and impact of integrating long-acting treatments into comprehensive HIV care and prevention programs
• Patient perspectives: research that examines patient experiences, preferences, and acceptability of long-acting therapies, addressing issues related to quality of life and treatment satisfaction
• Public health implications: studies evaluating the public health impact and cost-effectiveness of implementing long-acting treatments as part of HIV prevention and treatment strategies
• Mechanisms of action: investigations elucidating the mechanisms underlying the sustained action of long-acting treatments, including pharmacokinetics, drug delivery systems, and immunological responses
• Resistance and adherence: research exploring the potential emergence of drug resistance and the impact of long-acting treatments on adherence behaviors

This collection supports and amplifies research related to SDG 3: Good Health & Well-Being.

Image credit: gamjai / stock.adobe.com

Adblock test (Why?)